Thomas Scheier

566 total citations
33 papers, 249 citations indexed

About

Thomas Scheier is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Thomas Scheier has authored 33 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 10 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Thomas Scheier's work include COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and HIV/AIDS drug development and treatment (4 papers). Thomas Scheier is often cited by papers focused on COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and HIV/AIDS drug development and treatment (4 papers). Thomas Scheier collaborates with scholars based in Switzerland, Canada and United Kingdom. Thomas Scheier's co-authors include Silvio D. Brugger, Peter W. Schreiber, Philipp K. Buehler, Daniel A. Hofmaenner, Reto A. Schuepbach, Dominique L. Braun, Huldrych F. Günthard, Pascal M. Frey, Jürg Böni and Benjamin G. Hale and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Thomas Scheier

30 papers receiving 244 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Scheier Switzerland	10	144	52	41	37	30	33	249
Jaiprasath Sachithanandham United States	10	240 1.7×	32 0.6×	93 2.3×	38 1.0×	20 0.7×	36	358
Ikbel Hadj Hassine Tunisia	5	213 1.5×	73 1.4×	41 1.0×	38 1.0×	11 0.4×	7	312
Abigail E. Schiff United States	8	127 0.9×	40 0.8×	59 1.4×	47 1.3×	9 0.3×	11	210
Shannon C. Walker United States	6	225 1.6×	62 1.2×	29 0.7×	40 1.1×	17 0.6×	13	338
Matthew G. Zimmerman United States	9	199 1.4×	28 0.5×	78 1.9×	58 1.6×	16 0.5×	10	319
Stéphane Marot France	10	314 2.2×	49 0.9×	33 0.8×	27 0.7×	34 1.1×	32	378
Bosco Lam China	4	262 1.8×	48 0.9×	19 0.5×	23 0.6×	10 0.3×	6	298
Kwok Yung Yuen Hong Kong	4	285 2.0×	51 1.0×	19 0.5×	29 0.8×	9 0.3×	6	336
Ivan Fan Ngai Hung China	4	268 1.9×	48 0.9×	17 0.4×	24 0.6×	9 0.3×	4	303
Pedram Habibi Iran	5	144 1.0×	16 0.3×	30 0.7×	15 0.4×	8 0.3×	8	216

Countries citing papers authored by Thomas Scheier

Since Specialization

Citations

This map shows the geographic impact of Thomas Scheier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Scheier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Scheier more than expected).

Fields of papers citing papers by Thomas Scheier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Scheier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Scheier. The network helps show where Thomas Scheier may publish in the future.

Co-authorship network of co-authors of Thomas Scheier

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Scheier. A scholar is included among the top collaborators of Thomas Scheier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Scheier. Thomas Scheier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scheier, Thomas, et al.. (2025). Impact of sex on the development of bacteremia in critically ill burn patients: A retrospective cohort study. Burns. 52(2). 107845–107845. 1 indexed citations

Tepekule, Burcu, Weronika Barcik, Thomas Scheier, et al.. (2025). Computational and in vitro evaluation of probiotic treatments for nasal Staphylococcus aureus decolonization. Proceedings of the National Academy of Sciences. 122(7). e2412742122–e2412742122. 2 indexed citations

Butscheid, Yulia, Pascal M. Frey, Marc Pfister, et al.. (2025). Decline of antimicrobial resistance in Pseudomonas aeruginosa bacteraemia following the COVID-19 pandemic: a longitudinal observational study. Journal of Antimicrobial Chemotherapy. 80(7). 1837–1848.

Scheier, Thomas, Tafese Beyene Tufa, Torsten Feldt, et al.. (2025). Standard of care in advanced HIV disease: review of HIV treatment guidelines in sub-Saharan African countries—an extension study of eight countries. AIDS Research and Therapy. 22(1). 39–39. 1 indexed citations

Eikelboom, John W., Qilong Yi, William F. McIntyre, et al.. (2024). Results of the COMPASS Trial Analyzed Using Win Ratio Compared With Conventional Analytic Approaches. Canadian Journal of Cardiology. 40(11). 2171–2179. 2 indexed citations

Keller, Nadia, Mathilde Boumasmoud, Federica Andreoni, et al.. (2024). Investigating group A Streptococcus antibiotic tolerance in necrotizing fasciitis. mSphere. 9(9). e0063424–e0063424. 2 indexed citations

Scheier, Thomas, Thomas Stütz, Martin J. Hug, et al.. (2024). An outbreak of multi-drug-resistant Acinetobacter baumannii on a burns ICU and its control with multi-faceted containment measures. Journal of Hospital Infection. 146. 102–108. 5 indexed citations

Imkamp, Frank, Klara Haldimann, Silvio D. Brugger, et al.. (2024). Phenotypic and genotypic characterization of Neisseria gonorrhoeae isolates among individuals at high risk for sexually transmitted diseases in Zurich, Switzerland. International Journal of STD & AIDS. 35(6). 462–470. 1 indexed citations

West, Emily, Christina Grube, Herbert Kuster, et al.. (2023). Sustained Viral Suppression With Dolutegravir Monotherapy Over 192 Weeks in Patients Starting Combination Antiretroviral Therapy During Primary Human Immunodeficiency Virus Infection (EARLY-SIMPLIFIED): A Randomized, Controlled, Multi-site, Noninferiority Trial. Clinical Infectious Diseases. 77(7). 1012–1020. 9 indexed citations

10.

Schreiber, Peter W., et al.. (2023). Parallel dynamics in the yield of universal SARS-CoV-2 admission screening and population incidence. Scientific Reports. 13(1). 7296–7296. 2 indexed citations

11.

Scheier, Thomas, Juliane K. Franz, Mathilde Boumasmoud, et al.. (2023). Fourier-transform infrared spectroscopy for typing of vancomycin-resistant Enterococcus faecium : performance analysis and outbreak investigation. Microbiology Spectrum. 11(5). e0098423–e0098423. 7 indexed citations

12.

Hofmaenner, Daniel A., Thomas Scheier, Michelle L. Mayer, et al.. (2023). Enzymatic debridement with bromelain and development of bacteremia in burn injuries: A retrospective cohort study. Burns. 50(2). 405–412. 4 indexed citations

13.

Shambat, Srikanth Mairpady, Alejandro Gómez-Mejía, Markus Huemer, et al.. (2022). Hyperinflammatory environment drives dysfunctional myeloid cell effector response to bacterial challenge in COVID-19. PLoS Pathogens. 18(1). e1010176–e1010176. 19 indexed citations

14.

Andreoni, Federica, Claudio Acevedo, Thomas Scheier, et al.. (2022). Intervertebral disc cell chondroptosis elicits neutrophil response in Staphylococcus aureus spondylodiscitis. Frontiers in Immunology. 13. 908211–908211. 6 indexed citations

15.

Audigé, Annette, Jürg Böni, Peter W. Schreiber, et al.. (2021). Reduced Relative Sensitivity of the Elecsys SARS-CoV-2 Antigen Assay in Saliva Compared to Nasopharyngeal Swabs. Microorganisms. 9(8). 1700–1700. 11 indexed citations

16.

Scheier, Thomas, Christian Rüegg, Urs Karrer, et al.. (2021). Universal Admission Screening for SARS-CoV-2 Infections among Hospitalized Patients, Switzerland, 2020. Emerging infectious diseases. 27(2). 404–410. 18 indexed citations

17.

Huber, Michael, Peter W. Schreiber, Thomas Scheier, et al.. (2021). High Efficacy of Saliva in Detecting SARS-CoV-2 by RT-PCR in Adults and Children. Microorganisms. 9(3). 642–642. 35 indexed citations

18.

Shambat, Srikanth Mairpady, Clément Vulin, Sylvia Hoeller, et al.. (2021). Blunted sFasL signalling exacerbates TNF‐driven neutrophil necroptosis in critically ill COVID‐19 patients. Clinical & Translational Immunology. 10(12). e1357–e1357. 24 indexed citations

19.

Scheier, Thomas, Reto Schüpbach, Christian Falk, et al.. (2021). Implementation of daily chlorhexidine bathing in intensive care units for reduction of central line-associated bloodstream infections. Journal of Hospital Infection. 110. 26–32. 4 indexed citations

20.

Tepekule, Burcu, Anthony Hauser, Thomas Scheier, et al.. (2021). Assessing the potential impact of transmission during prolonged viral shedding on the effect of lockdown relaxation on COVID-19. PLoS Computational Biology. 17(1). e1008609–e1008609. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact